BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28583792)

  • 1. Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: A systematic review and meta-analysis.
    Almond LM; Hodson J; Ford SJ; Gourevitch D; Roberts KJ; Shah T; Isaac J; Desai A
    Eur J Surg Oncol; 2017 Oct; 43(10):1808-1815. PubMed ID: 28583792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon: meta-analysis.
    Van Den Heede K; Chidambaram S; Van Slycke S; Brusselaers N; Warfvinge CF; Ohlsson H; Nordenström E; Almquist M
    Br J Surg; 2022 Feb; 109(2):191-199. PubMed ID: 34941998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis.
    Zhou B; Zhan C; Ding Y; Yan S; Zheng S
    Onco Targets Ther; 2018; 11():975-982. PubMed ID: 29503572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.
    Capurso G; Rinzivillo M; Bettini R; Boninsegna L; Delle Fave G; Falconi M
    Br J Surg; 2012 Nov; 99(11):1480-6. PubMed ID: 22972490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours.
    Gurusamy KS; Pamecha V; Sharma D; Davidson BR
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007118. PubMed ID: 19160322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals.
    Kıvrak Salim D; Bayram S; Gömceli İ; Çekin AH; Karaca M; Koçer M; Yıldız M
    Turk J Gastroenterol; 2019 Oct; 30(10):910-916. PubMed ID: 31625933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
    Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
    Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
    J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours.
    Blažević A; Zandee WT; Franssen GJH; Hofland J; van Velthuysen MF; Hofland LJ; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2018 Mar; 25(3):245-254. PubMed ID: 29255095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tract.
    Goretzki PE; Mogl MT; Akca A; Pratschke J
    Rev Endocr Metab Disord; 2018 Jun; 19(2):169-178. PubMed ID: 30280290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
    Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M
    J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
    Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
    Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgery for GEP-NETs.
    Knigge U; Hansen CP
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):819-31. PubMed ID: 23582921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
    Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
    Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver Metastases.
    Kim MK; Ye F; Wang D; Cui M; Ward SC; Warner RR; Roayaie S; Shafir M; Schwartz M; Zhang D; Itzkowitz S
    Pancreas; 2016 Apr; 45(4):528-32. PubMed ID: 26474427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.
    Capurso G; Bettini R; Rinzivillo M; Boninsegna L; Delle Fave G; Falconi M
    Neuroendocrinology; 2011; 93(4):223-9. PubMed ID: 21358176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of neuroendocrine tumors.
    Tamburrino D; Spoletini G; Partelli S; Muffatti F; Adamenko O; Crippa S; Falconi M
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):93-102. PubMed ID: 26971846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management Strategies and Outcomes for Small Intestinal Neuroendocrine Tumours with Involvement of the Superior Mesenteric Vessels: A Systematic Review.
    Kmiotek E; Lakda S; Borakati A; Ogunbiyi O; Mandair D; Caplin M; Toumpanakis C; Mirnezami R
    Curr Oncol; 2023 Oct; 30(10):9192-9204. PubMed ID: 37887564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.
    Snorradottir S; Asgeirsdottir A; Rögnvaldsson S; Jonasson JG; Björnsson ES
    Cancer Epidemiol; 2022 Aug; 79():102197. PubMed ID: 35716441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical signs of fibrosis in small intestinal neuroendocrine tumours.
    Daskalakis K; Karakatsanis A; Stålberg P; Norlén O; Hellman P
    Br J Surg; 2017 Jan; 104(1):69-75. PubMed ID: 27861745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.